Clinical trial
Free Fatty Acids and Vascular Function in Subjects With Diabetes
NCT00153179 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00153179 |
|---|---|
| Title | Free Fatty Acids and Vascular Function in Subjects With Diabetes |
| Official title | The Impact of Free Fatty Acid Reduction on Vascular Function and Skeletal Muscle Glucose Utilization in Type 2 Diabetes Mellitus |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | acipimox, placebo |
| Enrollment | 40 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2011 |
| Completion | Mar 1, 2013 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 25, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: